Annual reports

Parissenti AM, Pritzker LB, Dahle MA, Gythfeldt HVL, Masilamani T, Theriault G, St-Onge R, D'costa L, Lingjaerde OC, Haugen MH, Engebraaten O (2025)
High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy
Breast Cancer Res, 27 (1), 143
DOI 10.1186/s13058-025-02092-9, PubMed 40790765

Brodal HP, Pharo H, Vedeld HM, Lind GE (2025)
PoDCall: a robust tool for automated droplet classification in DNA-methylation droplet digital PCR
Mol Oncol (in press)
DOI 10.1002/1878-0261.70105, PubMed 40761129

Radulovic M, Yang C, Stenmark H (2025)
Lysosomal membrane homeostasis and its importance in physiology and disease
Nat Rev Mol Cell Biol (in press)
DOI 10.1038/s41580-025-00873-w, PubMed 40759742

Sagini K, Selvarajah M, Romero S, Bassols-Citores E, Martin-Gracia B, Ramirez-Garrastacho M, Rise F, Endzeliņš E, Sadovska L, Skorinkina D, Boguševiča M, Cešeiko R, Čampa M, Klavina A, Linē A, Llorente A (2025)
The Redox Enzyme Thioredoxin Is Increased in Plasma Extracellular Vesicles From Endurance-Trained Females in Response to Acute Exercise
FASEB J, 39 (16), e70927
DOI 10.1096/fj.202500678R, PubMed 40810354

Stamnaes J, Stray D, du Pré MF, Risnes LF, Dewan AE, Shaik J, Stensland M, Lundin KE, Sollid LM (2025)
Interferon-γ is a direct driver of crypt hyperplasia in celiac disease
J Clin Invest (in press)
DOI 10.1172/JCI194858, PubMed 40828615

Nassar AH, Kim C, Adeyelu T, Bou Farhat E, Abushukair H, Rakaee M, Matteson K, Lau SF, Takabe Y, Ocejo A, Ardeshir-Larijani F, Leal T, Ramalingam S, Alam S, Gray JE, Hicks J, Kaldas D, Baena J, Berjaga MZ, Nana FA, Grohe C, Leuders H, Citarella F, Cortellini A, Mingo EC et al. (2025)
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma
Nat Commun, 16 (1), 7717
DOI 10.1038/s41467-025-63091-0, PubMed 40830141